Radiopharm Theranostics Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
Radiopharm Theranostics has a total shareholder equity of A$27.4M and total debt of A$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are A$72.0M and A$44.7M respectively.
Belangrijke informatie
0%
Verhouding schuld/eigen vermogen
AU$0
Schuld
| Rente dekkingsratio | n/a |
| Contant | AU$18.58m |
| Aandelen | AU$27.35m |
| Totaal verplichtingen | AU$44.68m |
| Totaal activa | AU$72.04m |
Analyse van de financiële positie
Kortlopende schulden: RAD's short term assets (A$22.8M) exceed its short term liabilities (A$17.6M).
Langlopende schulden: RAD's short term assets (A$22.8M) do not cover its long term liabilities (A$27.1M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: RAD is debt free.
Schuld verminderen: RAD had no debt 5 years ago.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: RAD has less than a year of cash runway based on its current free cash flow.
Voorspelling contante baan: RAD has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.4% each year